4//SEC Filing
TOWSE MATTHEW W 4
Accession 0001246360-18-001073
CIK 0001333170other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:28 PM ET
Size
10.1 KB
Accession
0001246360-18-001073
Insider Transaction Report
Form 4
TOWSE MATTHEW W
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2018-03-09−5,821→ 11,643 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (5,821 underlying) - Exercise/Conversion
Common Stock
2018-03-09+5,821→ 30,242 total - Award
Restricted Stock Unit
2018-03-09+17,464→ 17,464 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (17,464 underlying) - Tax Payment
Common Stock
2018-03-09$24.37/sh−1,846$44,987→ 28,396 total
Footnotes (1)
- [F1]Award granted pursuant to the 2017 Performance Share Plan, vesting in 3 equal annual installments beginning March 9, 2018.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001195852
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:28 PM ET
- Size
- 10.1 KB